Zacks Research Brokers Lift Earnings Estimates for Docusign

Docusign Inc. (NASDAQ:DOCU) – Equities research analysts at Zacks Research boosted their Q1 2027 earnings estimates for shares of Docusign in a report issued on Wednesday, December 24th. Zacks Research analyst Team now anticipates that the company will earn $0.32 per share for the quarter, up from their previous estimate of $0.30. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Docusign’s current full-year earnings is $1.17 per share.

Several other analysts also recently issued reports on the company. Piper Sandler decreased their target price on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a report on Wednesday, December 17th. BTIG Research began coverage on shares of Docusign in a report on Tuesday, December 16th. They issued a “buy” rating and a $88.00 target price on the stock. Wells Fargo & Company cut their target price on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating for the company in a research note on Friday, December 5th. Finally, Argus reiterated a “hold” rating on shares of Docusign in a report on Monday, September 8th. Six equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to MarketBeat, Docusign currently has an average rating of “Hold” and a consensus target price of $86.80.

Docusign Stock Down 0.6%

Shares of Docusign stock opened at $69.08 on Monday. The stock’s 50-day simple moving average is $69.03 and its 200-day simple moving average is $73.34. Docusign has a 52 week low of $63.41 and a 52 week high of $99.30. The company has a market capitalization of $13.83 billion, a price-to-earnings ratio of 48.31, a PEG ratio of 3.42 and a beta of 0.98.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in DOCU. IFP Advisors Inc lifted its stake in shares of Docusign by 31.9% in the 3rd quarter. IFP Advisors Inc now owns 1,955 shares of the company’s stock valued at $145,000 after purchasing an additional 473 shares during the last quarter. Strategic Advocates LLC bought a new stake in Docusign in the third quarter worth $50,000. CIBC Bancorp USA Inc. bought a new position in Docusign during the third quarter valued at $522,000. Centaurus Financial Inc. increased its position in Docusign by 3.4% during the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock valued at $402,000 after acquiring an additional 184 shares during the last quarter. Finally, Coldstream Capital Management Inc. raised its stake in shares of Docusign by 21.1% in the third quarter. Coldstream Capital Management Inc. now owns 4,147 shares of the company’s stock valued at $299,000 after acquiring an additional 723 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Transactions at Docusign

In other Docusign news, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $71.33, for a total value of $427,980.00. Following the completion of the transaction, the executive directly owned 58,968 shares of the company’s stock, valued at $4,206,187.44. This trade represents a 9.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director James A. Beer sold 450 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $68.54, for a total transaction of $30,843.00. Following the completion of the sale, the director owned 14,478 shares in the company, valued at approximately $992,322.12. This trade represents a 3.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 33,542 shares of company stock valued at $2,313,580 in the last 90 days. Company insiders own 1.66% of the company’s stock.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.